Synthetic Cannabinoids and ST-Elevated Myocardial Infarction: A Case Report and Literature Review

Cureus. 2023 May 19;15(5):e39236. doi: 10.7759/cureus.39236. eCollection 2023 May.

Abstract

The use of synthetic cannabinoids and marijuana has been known to be associated with myocardial infarction and coronary vasospasms according to a few case reports published for the pediatric population. The data on the use of synthetic cannabinoids and myocardial infarction in adults however is limited. The adverse effects of these so-called designer drugs have been far-reaching. Here, we describe a case of an adult male with ST-elevated myocardial infarction diagnosed secondary to smoking synthetic cannabinoids.

Keywords: addiction; cardiac chest pain; drug addiction; k2; marijuana abuse; st elevated myocardial infarction (stemi); synthetic cannabinoids.

Publication types

  • Case Reports